Based on the characteristic significant elevation of soluble CD30 levels in the serum and synovial fluid of RA patients, BV induces apoptosis in CD30-positive cells via its MMAE payload, exhibiting dose-dependent anti-inflammatory effects in mouse arthritis models. This evidence concerns the gene TNFRSF8 and arthritic joint disease.